ISOPTO ATROPINE Rx
Generic Name and Formulations:
Atropine sulfate 1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ISOPTO ATROPINE:
For mydriasis and/or cycloplegia. For cycloplegic refraction, for papillary dilation desired in inflammatory conditions of the iris and uveal tract.
Compress lacrimal sac by digital pressure for 2–3 minutes after instillation to avoid excessive systemic absorption. Uveitis: 1–2 drops in the eye(s) up to 4 times daily. Heavily pigmented irides may require larger doses.
Primary glaucoma or tendency toward glaucoma (eg, narrow anterior chamber angle).
Previous susceptibility to belladonna alkaloids; excessive use may produce systemic symptoms of atropine poisoning. Estimate depth of angle of anterior chamber to avoid inducing angle closure glaucoma. Infants. Pregnancy (Cat.C). Nursing mothers.
Prolonged use: follicular conjunctivitis, vascular congestion, edema, exudate, eczematoid dermatitis; hypotension, progressive respiratory depression (with excessive systemic absorption); children: coma, death possible.
- McDonald's and the Microbiome: What Effect Does Junk Food Have on Gut Bacteria?
- When the Doctor is Depressed: One Clinician Tells His Story
- Spice + Statin Likely Culprit in Patient with Acute Hepatitis
- Most Distinctive Causes of Death Mapped by U.S. State
- First Non-Surgical Tx for "Double Chin" Gains FDA Approval
- Heart Rate May Be an Indicator of Future Diabetes Risk
- Probiotic Mixture VSL#3 Shows Promise for Crohn's Recurrence
- Study: Beloranib Appears Safe, Efficacious for Weight Loss in Obesity
- Progress Toward Mind-Controlled Robotic Limbs
- Response to Resistance Exercise Depends on a Person's Genetic Risk for Obesity